Sugi Predict

Sugi Predict / Compounds / SCHEMBL2720899

SCHEMBL2720899

SCHEMBL2720899

CCCCCCC(C)(C)C(=O)OCC

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 2/20 0.76
▸ CYP4A11 Q02928 2/20 0.76
▸ MAPT P10636 2/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ ATM Q13315 1/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ HTT P42858 1/20 0.49
▸ THRB P10828 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ ELANE P08246 1/20 0.45
▸ PPARG P37231 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ CES2 O00748 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ ACAT1 P24752 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8249184 1.00 CYP4F2 (0.76) CYP4F2CYP4A11MAPTMEN1KMT2A
SCHEMBL29073392 1.00 CYP4F2 (0.76) CYP4F2CYP4A11MAPTMEN1KMT2A
SCHEMBL22748706 1.00 CYP4F2 (0.76) CYP4F2CYP4A11MAPTMEN1KMT2A
SCHEMBL21060863 1.00 CYP4F2 (0.76) CYP4F2CYP4A11MAPTMEN1KMT2A
SCHEMBL26632616 1.00 CYP4F2 (0.76) CYP4F2CYP4A11MAPTMEN1KMT2A
SCHEMBL2737131 0.98 CYP4F2 (0.72) CYP4F2CYP4A11MAPTMEN1KMT2A
Bromide SCHEMBL29061762 0.96 CYP4F2 (0.70) CYP4F2CYP4A11MAPTMEN1KMT2A
Bromide SCHEMBL28843573 0.94 CYP4F2 (0.68) CYP4F2CYP4A11MAPTMEN1KMT2A
SCHEMBL6254544 0.94 CYP4F2 (0.85) CYP4F2CYP4A11MAPTMEN1KMT2A
SCHEMBL6257314 0.94 CYP4F2 (0.85) CYP4F2CYP4A11MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010063955-A2 COSMETIC METHOD USING A COMPOSITION CONTAINING SILOXANE RESINS AND A NON-VOLATILE OIL L'OREAL (FR) 2010-06-10 — — WO claimed
WO-2009080964-A2 COSMETIC PROCESS USING A COMPOSITION COMPRISING A SILOXANE RESIN AND A NONVOLATILE OIL L'OREAL (FR) 2009-07-02 — — WO claimed
US-11760714-B2 Methods of making bempedoic acid and compositions of the same ESPERION THERAPEUTICS, INC. (US) 2023-09-19 — — US disclosed
CN-115491904-B Durable antibacterial garment 福建省尚飞制衣有限公司 2023-09-15 — — CN disclosed
US-20230250043-A1 METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAME GLAS AMERICAS LLC 2023-08-10 — — US disclosed
US-20230234917-A1 ASPARAGINE DERIVATIVES AND METHODS OF USING SAME SENDA BIOSCIENCES INC (US) 2023-07-27 — — US disclosed
US-20230234917-A1 ASPARAGINE DERIVATIVES AND METHODS OF USING SAME SENDA BIOSCIENCES INC (US) 2023-07-27 — — US disclosed
US-20230183160-A1 METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAME GLAS AMERICAS LLC 2023-06-15 — — US disclosed
CN-115491904-A Durable antibacterial garment 福建省尚飞制衣有限公司 2022-12-20 — — CN disclosed
WO-2021252640-A1 ASPARAGINE DERIVATIVES AND METHODS OF USING SAME SENDA BIOSCIENCES, INC. (US) 2021-12-16 — — WO disclosed
CN-112789121-A Coated metal plate and method for producing same 日本制铁株式会社 2021-05-11 — — CN disclosed
CN-102597122-A Curable composition KANEKA CORP 2012-07-18 — — CN disclosed
EP-2457567-A1 Agent having neurotrophic factor-like activity Nagoya Industrial Science Research Institute (JP) 2012-05-30 — — EP disclosed
EP-2457567-A1 Agent having neurotrophic factor-like activity Nagoya Industrial Science Research Institute (JP) 2012-05-30 — — EP disclosed
WO-2012054535-A2 COMPOUNDS, COMPOSITIONS AND METHODS USEFUL FOR CHOLESTEROL MOBILISATION CERENIS THERAPEUTICS SA (FR) 2012-04-26 — — WO disclosed
EP-2402300-A1 Hydroxyl compounds and compositions for cholesterol management and related uses Esperion Therapeutics Inc. (US) 2012-01-04 — — EP disclosed
EP-2204172-A1 AGENT HAVING NEUROTROPHIC FACTOR-LIKE ACTIVITY Nagoya Industrial Science Research Institute (JP) 2010-07-07 — — EP disclosed
EP-1740522-A2 BISPHENYL COMPOUNDS USEFUL AS VITAMIN D SB 3 /SB RECEPTOR AGONISTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-01-10 — — EP disclosed
US-20060025474-A1 Bisphenyl compounds useful as vitamin D3 receptor agonists CHUGAI SEIYAKU KABUSHIKA KAISHA (JP) 2006-02-02 — — US disclosed
WO-2005087700-A2 BISPHENYL COMPOUNDS USEFUL AS VITAMIN D3 RECEPTOR AGONISTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-09-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250043-A1 METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAME ALOX5, ALOX15, CYP27A1 CYP4F2 195/4885CYP4A11 53/4885MAPT 2118/4885
US-20230183160-A1 METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAME ALOX5, ALOX15, CYP27A1 CYP4F2 195/4885CYP4A11 53/4885MAPT 2118/4885
US-11760714-B2 Methods of making bempedoic acid and compositions of the same ALOX5, ALOX15, CYP27A1 CYP4F2 195/4885CYP4A11 53/4885MAPT 2118/4885
US-20230234917-A1 ASPARAGINE DERIVATIVES AND METHODS OF USING SAME ASNS, SI, NARS1 CYP4F2 2390/4885CYP4A11 3243/4885MAPT 3616/4885
US-20060025474-A1 Bisphenyl compounds useful as vitamin D3 receptor agonists VDR, CYP2R1, CYP24A1 CYP4F2 253/4885CYP4A11 195/4885MAPT 4560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.